Funding will be applied to further develop, commercialize, and license a pipeline of novel, non-invasive periodontal care products designed for patients suffering from periodontal disease at all stages of severity.

Co-Founded in 2022 with the scientific and clinical leadership of Dr. Tarun Ghosh and Dr. Thomas Hoover, ProEncia Biotechnology is a Minnesota-based innovative periodontal care company. ProEncia is focused on developing a new generation of easy-to-use, non-toxic, and non-invasive oral care options for adult patients at all stages of periodontal disease, including gingivitis and periodontitis. ProEncia's treatments are based on novel, patent-pending technology and include multiple prophylactic and therapeutic products.